Generic Name and Formulations:
Tobramycin 0.3%; oph. soln; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for TOBREX:
Susceptible infections of conjunctiva and cornea.
Adults and Children:
Severe infections: initially 2 drops every hr or ½ inch of ointment every 3–4 hrs; then may prolong dosing interval. Mild to moderate infections: 1–2 drops every 4 hrs or ½ inch of ointment 2–3 times daily.
Remove contact lenses before using. Pregnancy (Cat.B). Nursing mothers: not recommended.
Concomitant systemic aminoglycosides: monitor levels.
Superinfection, itching, swelling, erythema, sensitivity (discontinue if occurs); oint: may retard corneal healing.
Psychiatry Advisor Articles
- ADHD, Comorbid Bipolar Disorder Share Similar Neurocognitive Profiles
- Anxiety Prevention Interventions: How Effective Are They?
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- No Evidence of Personality Changes Prior to Developing Cognitive Impairment, Dementia
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Physicians Spend Nearly 6 Hours on EHR Tasks Per Day
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Hypertension Linked to an Increased Risk of Dementia?
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- Maternal Glucocorticoid Exposure Not Associated With ADHD in Offspring
- Ketamine Not Associated With PTSD Development in Military Trauma Setting
- Content, Quality Issues for Both Paper-Based and Electronic Health Records